←Front page
HealthNational
Lupus Foundation of America─supported phase II trial shows promise for mesenchymal stromal cells as a potential new lupus therapy
New data from the Lupus Foundation of America (LFA)–funded phase II Mesenchymal Stromal Cells in Systemic Lupus Erythematosus (MiSLE) trial, evaluating a single infusion of umbilical cord─derived mesenchymal
Balanced coverage
0% L100% C0% R
1 outlet covering this story
Bias Comparison
No AI summary generated for this bucket yet.
1 Article
- Lupus Foundation of America─supported phase II trial shows promise for mesenchymal stromal cells as a potential new lupus therapyPharma BizCenter
Discussion (0)
Sign in to share your opinion.
- No comments yet — be the first to weigh in.
